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Because of the occurrence of multiresistant bacterial strains in chronic infections of the urinary tract the physician is often faced with the necessity of choosing a therapeutic agent differing from those normally resorted to in the first instance. According to in vitro determinations, these multiresistant strains are often relatively sensitive to chloramphenicol. Treatment is often complicated by the occurrence of anatomical changes in the kidneys and the urinary tract, and by impairment of the renal function.
Most antibiotics are eliminated from the body by the kidneys, and so the concentration of such substances in the blood and urine is dependent on the renal function. If this function is impaired an antibiotic and its metabolites may be retained in the blood in concentrations which may have toxic effects (Erlanson and Lundgren, 1964) . When giving antibiotic therapy, therefore, the renal function should be taken into consideration, with regard to the risk of overdose as well as the difficulty of attaining a sufficient concentration in the urine. Kunin and Finland (1959) discussed the connexion between renal function and the excretion of various antibiotics. Principally, they found that if the concentration of the substance in the blood and the volume of urine are constant, then the concentration of the substance in the urine is directly proportional to the clearance of the substance and to the renal function. In treatment of the urinary tract, therefore, relatively high concentrations in the urine are attained if the substance is -excreted rapidly, even if the renal function of the patient is much impaired. On the other hand, antibiotics with low clearance values do not give effective urinary concentrations even in patients with good renal function, provided the serum concentrations of the substances are not raised very much. When estimating the renal function, determination of nonprotein-nitrogen and serum creatinine is often insufficient; considerable variation in the glomerular filtration may be found when these values are normal.
At the Renal Clinic of St. Eriks Sjukhus, Stockholm, we believe we have found an unsatisfactory correlation between the determination of the sensitivity of the bacterial strains in vitro and the results of chloramphenicol therapy. On reading the published reports of treatment with chloramphenicol in infections of the urinary tract we found varying results. Not unexpectedly, these were better when treating acute infections of the urinary tract than in the treatment of chronic cases (Chittenden et al., 1949; Hewitt and Williams, 1950; Turck et al., 1962 
Pharmacology of Chloramphenicol
Crystalline chloramphenicol is resorbed rapidly and almost completely from the gastrointestinal tract (Glazko et al., 1949; Schtick a al., 1959) . Maximal values in the blood are reached two to four hours after oral administration, and 75 to 90% is excreted in the urine within 24 hours (Ley et al., 1948; Chittenden et al., 1949; Glazko et al., 1949) . Less than 3% of administered chloramphenicol is excreted via the gall-bladder (Glazko et al., 1949) . The maximum concentration and speed of elimination-are propordional to the dose administered (Glazko ea al., 1949; Ley et al., 1948 ; Hewitt and Williams, 1950; Welch and Lewis, 1951) . Circulating chloramphenicol is rapidly conjugated in the liver to a monoglucuronide, which is bacteriologically inactive. About 60% of active chloramphenicol is bound to plasma proteins. Of the chloramphenicol excreted in the urine, only 5 to 15% of the dose administered is in the form of active chloramphenicol, the remainder consisting almost entirely of the inactive glucuronide (Chittenden et al., 1949; Glazko et al., 1949) . Active chloramphenicol is cleared by glomerular filtration. In normal individuals this has been estimated at 22 to 24 ml./minute (Glazko et al., 1949; Schtick et al., 1959) . The administration of a tubulus-blocking agent, probenecid, does not influence this clearance (Boger et al., 1951) . The inactive conjugated part is cleared by the tubuli, the rate in healthy individuals being 340 ml./minute (Glazko et al., 1949; Schtick et al., 1959) . The importance of the renal function for the concentration of chloramphenicol in the blood was studied by Kunin et al. (1959) 1-4, 1-6 2-5 0*5, 1.0
Material and Methods
The material consisted of 31 patients (see Table) in the medical ward of St. Eriks Sjukhus, Stockholm. They were chosen as representing various degrees of impairment of the renal function. Twenty were given a single dose of 1, 2, or 3 g. of chloramphenicol orally; 11 were given continuous therapy with a total daily dose of 1.5 to 3 g. of chloramphenicol.
Blood and urine were sampled at fixed intervals. In the patients who received the single dose such samples were taken every other hour during the first eight hours, and after this at longer intervals. Serum and urine were stored at --20' C. until the concentration tests were carried out.
The concentration of active chloramphenicol in the serum and urine was determined by means of the tube dilution method: 0.5 ml. of a 10-' dilution of an 18-hour culture of a Klebsiella pneumoniae strain' inhibited by 0.6 pug. (minimal inhibitory concentration) of chloramphenicol per ml. was added to 1 ml. of serum or urine diluted in twofold steps. The tubes were incubated at 37' C., read after 18 hours, shaken, and then re-read after 24 hours. The lowest serum or urine dilution giving inhibition of bacterial growth was taken as the concentration value of chloramphenicol. The sensitivity of the Klebsiella strain to chloramphenicol was checked each time.
The chemical method employed for determining chloramphenicol in the serum and urine was a modification of the method described by Bessman and Stevens (1950) . The nitrobenzol group was reduced with tin chloride, and the resulting aromatic amino-compound was diazotized and the colour read at 550 in a spectrophotometer.
By this method total chloramphenicol-i.e., active compound plus its metabolites-was determined.2
Concentration of Active Chloramphenicol and Its
Metabolites in the Blood Fig. 1 shows the concentration of active chloramphenicol as well as the concentration of total chloramphenicol in the blood. The material of patients was divided 'into three groups according to the state of renal function: group 1, with an endogenous creatinine clearance of 61-120 ml./minute ; group 2, with a clearance of 20-60 ml./minute; and group 3, with clearance values of less than 20 ml./minute. pig./ml. (Ley et al., 1948 ; Glazko et al., 1949) . If the renal function is only slightly impaired the percentage falls and lies, in the clearance range of 60-100 ml./minute, between 3.5 and 9. The majority of older patients, with a physiologically inhibited filtration, fell into this clearance range (Davies and Shock, 1950) . The 
Discussion
The therapeutic results of antibiotic administration in infections of the urinary tract vary, apart from the drug, chiefly an the composition of the patient-material and the duration of the follow-up. Provided that the bacteria in the urine are sensitive to the agents employed, a good effect is obtained initially. However, the longer the follow-up after discontinuation of the therapy the more frequent are the findings of relapse, either with the original infecting organism or with other bacteria, most often in patients with complicated or chronic disease of the kidneys or the urinary tract.
In the choice of antibiotic or chemotherapeutic agent it has often been discussed whether high concentrations in the serum and tissues or high concentrations in the urine are the most important for the treatment of urinary-tract infection. Logical reasons for the necessity of inducing inhibiting concentrations of antibiotics in the serum come readily to mind, but clinical support for this hypothesis has not been forthcoming. In their comparative studies in this field McCabe and Jackson (1965) did not find any proof for the necessity of inhibiting serum concentrations. On the other hand, they did find that inhibiting concentrations in urine were needed for satisfactory therapeutic results, even though such concentrations did not guarantee that the results would always be satisfactory. Inhibitory, usually bactericidal, concentrations in the urine were found in all patients who became free from bacteria. The view that it is necessary to have high concentrations in the urine is also supported by the fact that such agents as nitrofurantoin, which appear in the serum only at low concentrations, if at all, often have good therapeutic results. Our experience has also indicated that it is the concentrations in the urine which are the most important factors in the treatment of chronic infections of the urinary tract.
Our investigations showed that in patients with a normal renal function the maximum concentration of active chloramphenicol in the urine lay between 150 and 180 ttg./ml.
after the oral administration of 1 g. of chloramphenicol. These values correspond with already published results (Welch and Lewis, 1951) . The maximum values fall with increasing impairment of the renal function, and, as Fig. 3 shows, the excretion is linearly correlated to the glomerular filtration. The patients with an endogenous creatinine clearance value of less than 20 ml./minute showed maximum concentrations of chloramphenicol in the urine of 8-16 fug./ml., with a 24-hour mean concentration of 6-7 jug. In these patients, therefore, less than 1% of the dose administered was excreted in the form of active chloramphenicol.
The concentration of active chloramphenicol in the blood after a single oral dose did not give rise in our material to any obvious differences between the groups with differing renal function (Fig. 1) , Similar findings were attained by Kunin et ad. (1959) : the serum half-life of active chloramphenicol in normal individuals was 1.6-3.5 hours, and in anuric individuals 32-4.3 hours.
In patients with normal renal function the metabolites disappeared from the blood-stream after 48 hours, while in the group with impaired renal function the metabolites remained for as long as 10 days. These values also correspond with the results obtained by Kunin et al. (1959) ; the metabolite half-life in normal individuals was 3.7-4.6 hours, and in the anuric 68.5-154.3 hours. The retention of these chloramphenicol metabolites raises the question of whether the glucuronide may not also exercise a toxic effect on the bone-marrow. Studies on the importance of the concentration of active chloramphenicol and its metabolites in the serum, and on the renal function in cases of aplastic anaemia, have been reported on, but they do not seem to have been able to arrive at any definite conclusions (Rubin et al., 1958.; McCurdy, 1963; Suhrland and Weisberger, 1963) . Barber and Garrod (1963) caused by bacterial strains whose patterns of resistance exclude the usual primary agents-sulphanilamide, nitrofurantoin, and penicillins.
Summary
The excretion of biologically active chloramphenicol in urine diminishes linearly with decreasing renal function. When the renal function is reduced to an endogenous creatine clearance under 20 ml./min., less than 1% of the dose administered is excreted as the active compound, compared with 5-10% for normal renal function. The maximum excretion of chloramphenicol found at this degree of renal insufficiency was 10-20 fug./ml. of urine, compared with 150-200 ttg./ml. for normal renal function.
The low concentrations of urine might explain the poor correlation between chloramphenicol sensitivity tests in vitro and the results when treating infections of the urinary tract in patients with renal insufficiency. In elderly patients with a physiologically decreased renal filtration the urinary concentrations of chloramphenicol might be too low, increasing the risk for development of drug-resistant micro-organisms.
The level of biologically active chloramphenicol in blood was only slightly influenced by the renal function, while metabolites of the drug accumulated in patients with decreased renal function.
Control of the blood-pressure in hypertensive patients is now easier with drugs in current use. In the majority of patients blood-pressure can be reduced considerably, and usually, but not always, maintained at the desired level without undue sideeffects or intermittent hypotension. Consequently, with adequate drugs already available it is becoming more difficult to assess the relative merits of new preparations.
It takes at least 12 months to form a preliminary assessment of a promising new drug, and the first patients have usually been under treatment for two to three years before a confident opinion can be given on an adequate number of cases, particularly as regards tolerance.
In this country ganglion-blocking agents have been largely superseded by preparations which have no effect on the parasympathetic nervous system. At the present time most patients with severe hypertensive disease are probably being treated with the sympathetic-blocking drugs guanethidine or methyldopa, but clinical trials on new preparations are going on in many hospitals.
Patients vary in their preferences for different drugs largely owing to the varying side-effects.
Rather than carry out comparative trials or double-blind trials with different preparations in the same group, it is now sufficient to try different preparations only in those who cannot tolerate the drug with which most experience has been gained. (Lowther and Turner, 1963) .
Methyldopa proved to be equally effective as regards reduction of blood-pressure. On the whole, side-effects were fewer and less unpleasant, but some patients were completely intolerant of side-effects ; others felt generally unwell, and most experienced unpleasant symptoms in some degree (Johnson, Kitchin, Lowther and Turner, 1966) .
Some patients therefore preferred methyldopa and others guanethidine, but neither preparation was entirely satisfactory. Consequently we agreed to carry out a pilot trial with a new and more promising drug with an action reputed to be similar to that of guanethidine.
Debrisoquine sulphate (Declinax) was originally synthesized in 1961, and is a colourless, crystalline, water-soluble substance.
